share_log

4: Statement of changes in beneficial ownership of securities-10% Owner Nirland Ltd

SEC ·  Oct 3 05:05

Summary by Futu AI

Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Nirland Ltd, a shareholder in Conduit Pharmaceuticals (CDT.US), has engaged in a series of stock disposals from September 30, 2024, to October 2, 2024. The transactions involved the sale of a total of 2,600,000 shares of common stock at prices ranging from $0.1028 to $0.12 per share. The total market value of the disposed shares amounted to approximately $297,644.36. Following these transactions, Nirland Ltd's direct holdings in Conduit Pharmaceuticals decreased to 9,900,000 shares. The sales were executed as open market or private sales and are currently in progress.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated